| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Medical Officer
3 companies
Mansoor Raza Mirza is Director at SERA and has filed Form 4s across 3 companies. From December 2015 to July 2026, the filings on record show 0 open-market purchases and 35 sales. Mansoor Raza Mirza's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $223K at current prices.
Historically, Mansoor Raza Mirza's trades have earned a strong insider score of 79/100 across 17 rated trades. Over a 12-month horizon, 93.3% of those trades were profitable, with an average 12-month return of +37.3%.
The biggest single holding is SERA (~$158K) as Director. The SERA filings lean toward selling, a net 2,522 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 7, 2018 | KPTI Karyopharm Therapeutics Inc. | Director | Sale+OE | 1,500 | $13.00 | $19,500.00 | - | |
| Oct 2, 2017 | KPTI Karyopharm Therapeutics Inc. | Director | Sale+OE | 2,000 | $12.00 | $24,000.00 | - | |
| Sep 15, 2017 | KPTI Karyopharm Therapeutics Inc. | Director | Sale+OE | 2,882 | $11.00 | $31,702.00 | - | |
| Sep 11, 2017 | KPTI Karyopharm Therapeutics Inc. | Director | Sale+OE | 118 | $11.00 | $1,298.00 | - | |
| Dec 8, 2015 | KPTI Karyopharm Therapeutics Inc. | Director | Sale+OE | 15,000 | $15.01 | $225,136.50 | - |